NCT03679676: Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE) |
|
|
| Active, not recruiting | 2 | 108 | US | Omalizumab, Xolair, Dupilumab, Dupixent, Placebo | Stanford University, National Institute of Allergy and Infectious Diseases (NIAID), Food Allergy Research & Education, Harvard School of Public Health (HSPH) | Hypersensitivity, Food Allergy, Hypersensitivity, Food, Peanut Hypersensitivity, Peanut Allergy | 06/25 | 09/25 | | |
| Active, not recruiting | 1/2 | 264 | US, RoW | STMC-103H, Placebo | Siolta Therapeutics, Inc. | Atopic Dermatitis, Type 1 Hypersensitivity | 11/24 | 10/25 | | |